Yong Seo Koo

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Development of the clinical assessment scale in autoimmune encephalitis

Jung‐Ah Lim, Soon‐Tae Lee, Jangsup Moon et al. · Annals of Neurology · 2019 · 221 citations

Outdoor artificial light at night, obesity, and sleep health: Cross-sectional analysis in the KoGES study

Yong Seo Koo, Jinyoung Song, Eun Yeon Joo et al. · Chronobiology International · 2016 · 155 citations

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Pitfalls in Using Electrophysiological Studies to Diagnose Neuromuscular Disorders

Yong Seo Koo, Charles S. Cho, Byung‐Jo Kim · Journal of Clinical Neurology · 2012 · 58 citations · Full text

Neurological Disorder, Diagnosis, Electrophysiological Studies +19